Laboratory Results Summary

Similar documents
DAT-B 2015 Direct Antiglobulin Test

VM-A 2011 Viral Markers

PROFICIENCY TESTING. Clinical Laboratory Improvement Amendments (CLIA) DOs and DON Ts. Brochure # 8

M E D I C A L L A B O R A T O R Y

M E D I C A L L A B O R A T O R Y

M E D I C A L L A B O R A T O R Y

M E D I C A L L A B O R A T O R Y

M E D I C A L L A B O R A T O R Y

Transfusion Medicine (Comprehensive, Limited) J, J1

M E D I C A L L A B O R A T O R Y

M E D I C A L L A B O R A T O R Y

M E D I C A L L A B O R A T O R Y

CLIA APPROVED PROFICIENCY TESTING PROGRAMS ACCUTEST, INC. P.O. Box 999 Westford, Massachusetts (800)

Proficiency Testing LABFACTS Requirements for good laboratory practice and COLA Laboratory Accreditation programs are underlined.

REFERENCE LABORATORY. Regular Hours - Monday through Friday 8:00 AM to 4:00 PM. On-Call Staff - Evenings, Nights, Weekend and Holidays.

Primary Sample Manual Infectious Serology Issue No Effective Date: 20/09/17 Page 1 of 15 EUROFINS BIOMNIS

Reflex Test Protocols

INSTRUCTIONS FOR BLOOD BANK INSPECTION CHECKLIST AND REPORT CMS-282

Reflex Test Protocols

Learning Objectives. New HIV Testing Algorithm from CDC. Overview of HIV infection and disease 3/15/2016

Controls & Calibrators. Disease Quality Controls

Transfusion Reactions. Directed by M-azad March 2012

READ HIGHLIGHTED CHANGES

q,a;e Fc ) ORIGINAL EVALUATION. FH9-B 2017 Hematology Auto Differentials, FH9

HIV Viral Load Quality Assessment Program Summary for Panel HIVVL 2017Oct27

Blood transfusion. Dr. J. Potgieter Dept. of Haematology NHLS - TAD

Immunohematology. IH-QC Modular System. Select. Combine. Control.

The testing of Donated Blood and Components at NHSBT

Disclosures. Relevant Financial Relationship(s): Nothing to Disclose. Off Label Usage: Nothing to Disclose 9/19/2017. Proficiency Testing

AccuVert HBV Seroconversion Panel PHM941(M) ( )

Uniplas Das Einheitsplasma für jedermann

SOURCES OF ERROR IN SEROLOGIC AND IMMUNOLOGIC LAB. Lecture by: Dr. Forouzan Karimi; PharmD, PhD

TEST REQUEST INFORMATION- VIROLOGY

Frequency of occult hepatitis B in HBsAg seronegative blood donors in a tertiary care hospital in kerala,south India.

HIV Viral Load Quality Assessment Program Summary for Panel HIVVL 2018Oct26

NLBCP-017 INDIRECT ANTIGLOBULIN CROSSMATCH TUBE METHOD. Issuing Authority

MP Biomedicals Asia Pacific Pte. Ltd. (formerly Genelabs Diagnostics Pte. Ltd.)

PROPOSED USE This method is used for determining plasma reagins in human sera.

Susanne Norris Zanto, MPH, MLS (ASCP) CM, SM Montana Public Health Laboratory

2019 HIV Diagnostics Conference March 27, 2019

The Alphabet Soup of Viral Hepatitis Testing

Diagnostic Methods of HBV infection. Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO)

SOLE-SOURCE DETERMINATION

TRANSFUSION REACTIONS

PRODUCT CATALOGUE YOUR GLOBAL PARTNER IN DIAGNOSTICS

Trends in molecular diagnostics

Duration: 12 months May to April

AccuVert HIV-1 Seroconversion Panel PRB955 ( ) / Batch #

AIHA The Laboratory Perspective on Testing. Tom Bullock Joint UK NEQAS (BTLP) & BBTS BBT SIG Annual Meeting 20 th November 2018

Guidance for Industry

DS-EIA-ANTI-HIV-UNIF (Ab) I DS-EIA-ANTI-HIV-UNIF (Ab) I DS-EIA-ANTI-HIV-UNIF (Ab) I

2014/LSIF/PD/025 Malaysia s Approach to Testing Strategies

Bulk Assay Supply Catalog

FINAL REPORT HBV Serology External Quality Assessment Scheme

AccuSet HBV Worldwide Performance Panel

Evolution of HIV Diagnostics. Goals for the 2010 Conference. Bernard M. Branson, M.D. CDC Division of HIV/AIDS Prevention

ORIGINAL EVALUATION. FH9-C 2017 Hematology Auto Differentials, FH9

PILOT STUDY OF ANTIGEN MATCHING FOR AUTOIMMUNE HEMOLYTIC ANEMIA

MEDICAL DEVICE GUIDANCE DOCUMENT

Documentation, Codebook, and Frequencies

Reporting from Council of Europe member states on the collection, testing and use of blood and blood components in Europe The 2006 Survey

Brrrr, It s Cold In Here

Multichem Infectious Disease QC

Tel: Tel: Web: CODE DESCRIPTION UNITS

Official Journal of the European Communities COMMISSION

AccuSet Autoimmune Performance Panel

Answering your daily challenges. in the ELISA technology I N FECTI OUS DISEASES. bioelisa

ELISA kits for infections (HIV; Hepatitis A, B, C, D, E; Syphilis, ToRCH and others), hormone pathologies and tumor markers.

2014 Continuing Compliance Master Series Best Practices in Alternative Assessment of Performance

Parvovirus B19 Mixed Titer Performance Panel PVP201

Principles of In Vitro Diagnostic (IVD) Medical Devices Classification

Structure and duties of Blood service

Lab Guide Blood Bank Section Lab Guide

G-B 2016 Kit Instructions CAP 2016

Blood Screening Assays. CTS lab locations where assays are performed are indicated by alpha codes D, P, and T.

See external label 2 C-8 C 96 tests Chemiluminescence. CMV IgM. Cat # Diluted samples, controls & calibrator 100 µl 30 minutes

DIAGNOSTIC AUTOMATION, INC.

Taken From VBA s Adjudication Procedure Manual Section on Hepatitis

Study of ChLIA and ELISA for TTI Markers in Blood Donors

2. Liver blood tests and what they mean p2 Acute and chronic liver screen

True Status A B. HTLV I Positive. Indeterminate. HTLV I/II Negative HV15 HV16 HV18 HV21 HV22 HV44 HV55. Selected Legend: Flagged: Unresolved

Proficiency Testing Evaluation

Significance of Antibodies and appropriate selection of red cells for transfusion Chris Elliott Haematology Service manager

HIV-1 AccuVert Seroconversion Panel (PRB966) / Batch #

Non-reproductive tissues and cells Recommending authority/ association

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

BIO-FLASH. BIOKIT, S.A. - Can Malé s/n Lliçà d Amunt - Barcelona - SPAIN

BLOOD SAFETY STATUS IN INDONESIA. Yuyun Soedarmono Chairman of the Indonesian Association of Transfusion Medicine

Results of the College of American Pathologists (CAP) Proficiency Program for CMV, EBV, and BKV Viral Load Testing

NEWS BK NEWS # 378 /MKT DATE : TITLE. Dear colleagues,

Immunohaematology: a branch of immunology that deals with the immunologic properties of blood.

Quality Control Solutions

2. Liver blood tests and what they mean p2 Acute and chronic liver screen

8/28/2018. Disclosures. Objectives. None. Automation to PreciseType and Everything in Between

Automation to PreciseType and Everything in Between. Jessie Singer MT(ASCP) Transfusion Medicine Children s Hospital Los Angeles

Product List Autobio Diagnostics Autobio. autobio diagnostics an autobio group company

Turbidos. Design Verification. Contents

Test Name Results Units Bio. Ref. Interval

Innovation in Diagnostics. ToRCH. A complete line of kits for an accurate diagnosis INFECTIOUS ID DISEASES

WHO Prequalification of In Vitro Diagnostics Programme

Transcription:

Laboratory Results Summary Laboratory CO1033AI Test event 2 of 3 CAP LAP Number 7181660 Page Print Date 9 / 10 2008/Jul/04 Program Syphilis (SYPH435) Results Deadline 2008/Jun/24 Subscription ID Analyte Result Reason Grade Actual Score Code Results Count Statistical Count Results Answer % PG: Method/Submethod Instrument Reagent» Syphilis qualitative 32221 100% A Reactive ACC 27 1 Reactive 100% ID: Immunoassay/Enzymatic Manual determination Organon Teknika SpiroTek Weak Reactive 0% Reagin II B Reactive ACC 27 1 Reactive 100% ID: Immunoassay/Enzymatic Manual determination Organon Teknika SpiroTek Weak Reactive 0% Reagin II C Non Reactive ACC 27 1 Non Reactive 100% ID: Immunoassay/Enzymatic Manual determination Organon Teknika SpiroTek Reagin II D Non Reactive ACC 27 1 Non Reactive 100% ID: Immunoassay/Enzymatic Manual determination Organon Teknika SpiroTek Reagin II E Reactive ACC 27 1 Reactive 100% ID: Immunoassay/Enzymatic Manual determination Organon Teknika SpiroTek Weak Reactive 0% Reagin II Grade: ACC - ; UNACC - Unacceptable; *ACC or *UNACC (i.e. grade preceded by an asterisk) indicates ungradable due to lack of (80%) peer group concensus or insufficient peer group.» This result is designated for regulatory purposes. Peer Group(PG) Codes: AR-all results; ME-method; SM-submethod; RM-reagent manufacturer; RG-reagent group; RE-reagent; IM-instrument manufacturer; IG-instrument group; ID-instrument model Reason Codes: 1(Failure to participate (0% score)); 11(below linear/detection limit); 2(Failure - Excl Requested (100% score)); 22(above linear/detection limit); 88(testing suspended during test event);

EVALUATION DAT-A 2008 Direct Antiglobulin Test INSTITUTION: ATTENTION: CAP NUMBER: 7181660-01 Kit# 1 KIT INFORMATION: Kit ID: 20617542 2/4/2008 3/17/2008 Next Mailing Date: 10/13/2008 COPIED TO: LAP CAP LEGEND: Exception Reason Codes appearing in this evaluation: [27] = Lack of participant or referee consensus. Reviewed By Date Page 1 of 2

DAT-A 2008 Direct Antiglobulin Test Test Method Specimen Your Result Intended Response Your Grade DAT Poly GEL TESTING DAT-01 20617542 2/4/2008 3/17/2008 DAT-02 DAT-03 NEGATIVE NEGATIVE DAT IgG GEL TESTING DAT-01 NEGATIVE Unacceptable DAT-02 DAT-03 NEGATIVE NEGATIVE DAT C3d GEL TESTING DAT-01 DAT-02 [27] DAT-03 NEGATIVE NEGATIVE Page 2 of 2

EVALUATION J-A 2008 Transfusion Medicine (Comp) INSTITUTION: ATTENTION: CAP NUMBER: 7181660-01 Kit# 1 KIT INFORMATION: Kit ID: 20618267 2/11/2008 3/24/2008 Next Mailing Date: 6/16/2008 COPIED TO: LAP CAP LEGEND: Exception Reason Codes appearing in this evaluation: [11] = Unable to analyze (documentation to be provided by laboratory). [26] = Educational challenge. Reviewed By Date Page 1 of 8

J-A 2008 Transfusion Medicine (Comp) Test Method Specimen Your Result Intended Response Your Grade ABO Group J-01R GROUP A GROUP A GROUP A1 20618267 2/11/2008 3/24/2008 J-02R GROUP A GROUP A GROUP A1 J-03R GROUP O GROUP O J-04R GROUP AB GROUP AB GROUP A1B J-05R GROUP O GROUP O Rh Type J-01R RH RH J-02R RH RH J-03R RH RH J-04R RH NEGATIVE RH NEGATIVE J-05R RH RH Page 2 of 8

J-A 2008 Transfusion Medicine (Comp) Test Method Specimen Your Result Intended Response Your Grade Antibody Detection J-01S ANTIBODY DETECTED ANTIBODY DETECTED 20618267 2/11/2008 3/24/2008 J-02S ANTIBODY NOT DETECTED ANTIBODY NOT DETECTED J-03S ANTIBODY NOT DETECTED ANTIBODY NOT DETECTED J-04S ANTIBODY DETECTED ANTIBODY DETECTED J-05S ANTIBODY DETECTED ANTIBODY DETECTED Antibody ID J-01S J-02S J-03S J-04S J-05S [11] [11] [11] [11] [11] Crossmatch Serology J-01S J-02S J-03S J-04S J-05S C Type J-06R 4+ [26] Page 3 of 8

J-A 2008 Transfusion Medicine (Comp) Test Method Specimen Your Result Intended Response Your Grade E Type J-06R NEGATIVE 0 [26] c Type J-06R 4+ [26] e Type J-06R 4+ [26] 20618267 2/11/2008 3/24/2008 Page 4 of 8

J-A 2008 Transfusion Medicine (Comp) 20618267 2/11/2008 3/24/2008 CAP #: 2007 2 Regulated Analyte Test Event Score % Unexpected Antibody Det CAP 7181660 Subspecialty : Unexpected Antibody Det 2007 3 Test Event Score % Test Event Score % JAT-B 5 / JAT-C J-A 2008 1 Current Event Cumulative CLIA Performance '88 Performance Interpretation Interpretation Satisfactory Unexpected Antibody Det Satisfactory Page 5 of 8

J-A 2008 Transfusion Medicine (Comp) 20618267 2/11/2008 3/24/2008 ABO Group Rh (D) Type CAP #: 2007 2 Regulated Analyte Test Event Score % CAP 7181660 Subspecialty : ABO Group/Rh Type 2007 3 Test Event Score % Test Event Score % JAT-B 5 / JAT-C J-A JAT-B 5 / JAT-C J-A 2008 1 Current Event Cumulative CLIA Performance '88 Performance Interpretation Interpretation Satisfactory Satisfactory ABO Group/Rh Type 10/10 100 10/10 100 10/10 100 Satisfactory Page 6 of 8

J-A 2008 Transfusion Medicine (Comp) 20618267 2/11/2008 3/24/2008 CAP #: 2007 2 Regulated Analyte Test Event Score % Antibody Identification CAP 7181660 Subspecialty : Antibody Identification 2007 3 Test Event Score % Test Event Score % J-A 2008 1 Current Event Cumulative CLIA Performance '88 Performance Interpretation Interpretation 5 100 Satisfactory Antibody Identification Satisfactory Page 7 of 8

J-A 2008 Transfusion Medicine (Comp) 20618267 2/11/2008 3/24/2008 CAP #: 2007 2 Regulated Analyte Test Event Score % Compatibility Testing CAP 7181660 Subspecialty : Compatibility Testing 2007 3 Test Event Score % Test Event Score % J-A 2008 1 Current Event Cumulative CLIA Performance '88 Performance Interpretation Interpretation 5 100 Satisfactory Compatibility Testing Satisfactory Page 8 of 8

EVALUATION VM-B 2008 Viral Markers INSTITUTION: ATTENTION: CAP NUMBER: 7181660-01 Kit# 1 KIT INFORMATION: Kit ID: 20618208 12/2008 6/12/2008 Next Mailing Date: 8/22008 COPIED TO: LAP CAP LEGEND: Exception Reason Codes appearing in this evaluation: <NONE> Reviewed By Date Page 1 of 5

VM-B 2008 Viral Markers Test Method Specimen Your Result Intended Response Your Grade HBsAg FLUORESCENT EIA VM1-14 20618208 12/2008 6/12/2008 VM1-15 VM1-16 VM1-17 VM1-18 Anti-HBs FLUORESCENT EIA VM1-14 VM1-15 VM1-16 VM1-17 VM1-18 Page 2 of 5

VM-B 2008 Viral Markers Test Method Specimen Your Result Intended Response Your Grade Anti-HAV(IgM) FLUORESCENT EIA VM1-14 20618208 12/2008 6/12/2008 VM1-15 VM1-16 VM1-17 VM1-18 Anti-HIV 1/2 RECOMBINANT EIA VM1-14 VM1-15 VM1-16 VM1-17 VM1-18 Page 3 of 5

VM-B 2008 Viral Markers Test Method Specimen Your Result Intended Response Your Grade Anti-HCV ABBOTT VM1-14 20618208 12/2008 6/12/2008 VM1-15 VM1-16 VM1-17 VM1-18 Page 4 of 5

VM-B 2008 Viral Markers 20618208 12/2008 6/12/2008 CAP #: 2007 3 Regulated Analyte Test Event Score % Alpha-1-Antitrypsin Alpha-Fetoprotein Antinuclear Antibody Antistreptolysin O Anti-HIV Complement C3 Complement C4 Hepatitis (HBsAg) IgA IgG IgE CAP 7181660 Subspecialty : General Immunology 2008 1 S-C 5 / S-A K-C 5 / K-A S-C 5 / S-A S-C 5 / S-A Test Event Score % Test Event Score % VM-C 5 / VM-A VM-B S-C 4 / 5 80 S-A S-C 5 / S-A VM-C 5 / VM-A VM-B S-C 5 / S-A S-C 5 / S-A S-C 5 / S-A 4/ 5 80 2008 2 Current Event Cumulative CLIA Performance '88 Performance Interpretation Interpretation Satisfactory Satisfactory IgM S-C 3 / 5 60 S-A <1> Rheumatoid Factor S-C 5 / S-A General Immunology 62/65 95 64/65 98 10/10 100 Satisfactory <1> Currently successful - At risk for the next mailing. Page 5 of 5